SOFTOX SOLUTIONS NK 002
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing p… Read more
SOFTOX SOLUTIONS NK 002 (6FV) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, SOFTOX SOLUTIONS NK 002 (6FV) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SOFTOX SOLUTIONS NK 002 - Net Assets Trend (None–None)
This chart illustrates how SOFTOX SOLUTIONS NK 002's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SOFTOX SOLUTIONS NK 002 (None–None)
The table below shows the annual net assets of SOFTOX SOLUTIONS NK 002 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to SOFTOX SOLUTIONS NK 002's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
SOFTOX SOLUTIONS NK 002 Competitors by Market Cap
The table below lists competitors of SOFTOX SOLUTIONS NK 002 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Indiana Resources Ltd
AU:IDA
|
$10.00 Million |
|
Airo Lam limited
NSE:AIROLAM
|
$10.00 Million |
|
PT Master Print Tbk
JK:PTMR
|
$10.00 Million |
|
GRAFT POLYMER UK LS -001
F:J4I
|
$10.00 Million |
|
Algorae Pharmaceuticals Ltd
AU:1AI
|
$9.99 Million |
|
Nila Infrastructures Limited
NSE:NILAINFRA
|
$9.99 Million |
|
Bonia Corporation Bhd
KLSE:9288
|
$9.99 Million |
|
MSP Recovery Inc.
NASDAQ:LIFW
|
$9.98 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SOFTOX SOLUTIONS NK 002's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares SOFTOX SOLUTIONS NK 002's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently SOFTOX SOLUTIONS NK 002 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares SOFTOX SOLUTIONS NK 002's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,291,084,078
- Average return on equity (ROE) among peers: -24.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SOFTOX SOLUTIONS NK 002 (6FV) | €- | N/A | N/A | $10.00 Million |
| 09R (09R) | $-3.01 Million | 0.00% | 0.00x | $11.12 Million |
| IDORSIA AG (19T) | $-968.72 Million | 0.00% | 0.00x | $532.51 Million |
| 1S90 (1S90) | $-44.86 Million | 0.00% | 0.00x | $51.72 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.31 Million |
| 25K0 (25K0) | $-16.66 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $-37.78 Million | 0.00% | 0.00x | $6.23 Million |
| Intervacc AB (publ) (2E9) | $237.93 Million | -43.23% | 0.09x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $14.92 Million | -17.30% | 0.56x | $9.25 Million |
| GNI Group Ltd (3G6) | $13.72 Billion | -1.46% | 0.26x | $772.60 Million |